KFDA Releases Advisory Statement on Methotrexate

Published: 2005-02-17 06:56:00

Updated: 2005-02-17 06:56:00

The Korea Food and Drug Administration (KFDA) released an advisory statement on February 14th to the healthcare professionals and pharmacists on the reported mortality instances in Japan by medications containing methotrexate, which is indicated for treatment of certain types of cancer and of inf...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK